Mexico - Delayed Quote MXN

VanEck Pharmaceutical ETF (PPH.MX)

1,510.00 0.00 (0.00%)
At close: March 13 at 11:23 AM CST

Top 10 Holdings (63.83% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 11.78%
NVO
Novo Nordisk A/S 9.44%
JNJ
Johnson & Johnson 6.68%
MRK
Merck & Co., Inc. 6.24%
ABBV
AbbVie Inc. 6.08%
AZN
AstraZeneca PLC 5.15%
NVS
Novartis AG 4.72%
COR
Cencora, Inc. 4.62%
MCK
McKesson Corporation 4.56%
PFE
Pfizer Inc. 4.55%

Sector Weightings

SectorPPH.MX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 100.01%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.03
Price/Book 0.28
Price/Sales 0.75
Price/Cashflow 0.07
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

ETF Overview

Category Health
Fund Family VanEck
Net Assets 543.21M
YTD Daily Total Return --
Yield --
Legal Type Exchange Traded Fund

Related Tickers